Company Overview

Development Stage

About the Company

[Summary] 创新药物研发商

仁景(苏州)生物科技有限公司成立于2021年,致力于研究开发RNA创新药物及相关技术平台,核心团队成员来自MNC、协和及全球知名院所。公司凭借深厚的技术储备,制药工业经验及管理能力,高效推进FIC/BIC产品管线及坚实的技术平台。公司深度布局重大疾病的interceptive治疗性药物、蛋白替代抗衰疗法、及创新多模式的RNA平台疗法;平台属性深度赋能开发效率及研发成功率。其中,HPV相关疾病治疗性药物临床表现优异,Phase IIb入组进行中。
公司自建多重强化的靶向递送技术(tLNP)、线状mRNA及环状RNA平台、及AI fHealthcare自主技术平台。拥有国际布局的全链条自主知识产权,确保产品的全球市场收益,创新驱动,打造强有力的国际竞争力。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (7 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2亿人民币
  • Investor: 投资方未透露

How Fast Is Hiring Growing? (11 open positions)

Manage
Note: How fast is hiring at 仁景(苏州)生物科技有限公司 growing? 2026: 29 openings (up 383%), 2025: 6 openings (down 78%), 2024: 27 openings (up 200%), 2023: 9 openings (down 72%), 2022: 32 openings (down 24%), 2021: 42 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 85%
  • 2024: Up 225%
  • 2023: Down 69%
  • 2022: Up 333%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 仁景(苏州)生物科技有限公司 growing? Master's recruitment over the years: 2025: 2 openings (down 85%), 2024: 13 openings (up 225%), 2023: 4 openings (down 69%), 2022: 13 openings (up 333%), 2021: 3 openings.

Doctoral Degree Job Demand Analysis

(More)
+400%
Growth Rate
2026 vs 2025
  • 2025: Down 67%
  • 2024: Up 50%
Doctoral Hiring by Year: 2026 — 4 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 仁景(苏州)生物科技有限公司 growing? Doctorate recruitment over the years: 2026: 5 openings (up 400%), 2025: 1 openings (down 67%), 2024: 3 openings (up 50%), 2023: 2 openings.

— What Are the Salaries Like? (29 records)

Manage
salary range: 2K - 50K, 65.5% of roles pay ¥20-50K
Note: salary statistics are based on 29 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 仁景(苏州)生物科技有限公司?65.5% of positions earn 20-50K, Undergraduate salary: ¥。Suzhou salary ranking top 25,经营管理类 average salary ¥28.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 仁景(苏州)生物科技有限公司? We provide: 临床,研究员,化学,知识产权,分析,研发经理,质量,高级专员,高级经理,ai工程师,bd,hr,sa,会计,制剂经理,助理经理,医学经理,实习生,注册主管,注册经理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 经营管理类
    51.7% of total 51.7%
  • 医疗卫生/美容保健类
    27.6% of total 27.6%
  • 生物/制药/化工/环保类
    24.1% of total 24.1%
  • 其他(研发和技术类)
    20.7% of total 20.7%

Education

  • 本科
    44.8% of total 44.8%
  • 硕士
    37.9% of total 37.9%
  • 博士
    17.2% of total 17.2%

Experience

  • 5-10年
    65.5% of total 65.5%
  • 3-5年
    24.1% of total 24.1%
  • 不限
    10.3% of total 10.3%
View Detailed Analysis

What does 仁景(苏州)生物科技有限公司 require? Who is 仁景(苏州)生物科技有限公司 hiring? recruitment: 经营管理类占比最多占51.7%,其次是医疗卫生/美容保健类占27.6%. What education can get in at ? 本科占比最多占44.8%,其次是硕士占37.9%. High education required at ? 硕士占37.9%,博士占17.2%. Work experience required at ? 5-10年占比最多占65.5%,其次是3-5年占24.1%. Where are the job locations at ? 苏州占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 7,640.4312万(元)
Legal Representative: YIJIE DONG
Date Established:
Credit Code: 91320594MA258EH3XU
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区桑田街218号生物医药产业园二期C区24号楼201单元

People who follow this company also follow

Competitors (Similar Companies)

“新型小核酸药物的生物制药公司”
“To develop high-quality biologics that are accessible and affordable f”
“Exploring scientific research and education systems and mechanisms sui”
生物科技/生物工程 医药 蛋白质工程 生物医药
“为全球肿瘤患者带来更好的治疗方案”
“致力于以AAV载体为代表的基因和细胞治技术的开发和应用、能够为基因治疗产业化提供整体解决方案”
医药 生物医药 药物研发 mRNA
“Managing health, creating brightness”
医药 药物研发 大健康 药材种植
“创造更多高效、优质,低价的生物大分子药物”
制药/药业 医药 生物制药 神经系统疾病药物
证券 证券经纪 证券自营 资产管理
数据服务 档案数字化 信息安全管理 IT服务
电气 变频器 自动化 伺服驱动器
模式识别 生命科学 纳米材料 成像系统

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates